B-Raf serine-threonine kinase (BRAF) inhibitors
A DrugBank category of 4 drugs. 4 of them are approved.
- ATC classification
What you can answer from here — as of August 31, 2022
Which targets do B-Raf serine-threonine kinase (BRAF) inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account